Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia

• Shovik Bandyopadhyay ,

  Contributed equally to this work with: Shovik Bandyopadhyay, Junjie Li

  Affiliation Department of Biological Sciences, Purdue University, West Lafayette, Indiana, United States of America

  ⨯
• Junjie Li ,

  Contributed equally to this work with: Shovik Bandyopadhyay, Junjie Li

  Affiliation Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America

  ⨯
• Elie Traer,

  Affiliation Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Jeffrey W. Tyner,

  Affiliations Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America, Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Amy Zhou,

  Affiliation Division of Hematology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Stephen T. Oh ,

  * E-mail: jcheng@purdue.edu (JXC); stoh@dom.wustl.edu (STO)

  Affiliation Division of Hematology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Ji-Xin Cheng

  * E-mail: jcheng@purdue.edu (JXC); stoh@dom.wustl.edu (STO)

  Affiliations Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America, Center for Cancer Research, Purdue University, West Lafayette, Indiana, United States of America

  http://orcid.org/0000-0002-5607-6683

  ⨯